Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways
Frontiers in Cell and Developmental Biology · 22.08.2023 · 11
DOI: 10.3389/fcell.2023.1202888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 22.08.2023. Verfasst von Yuhao Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Dragon’s Blood resin (DBR) is a traditional medicinal substance renowned for its diverse pharmacological effects, which consists of potent anti-inflammatory, antioxidant and angiogenic properties. This study aimed to elucidate its therapeutic mechanism in alleviating steroid-induced osteonecrosis of the femoral head (SIONFH).
Methods
Techniques such as SPR and LC-MS were employed to identify and analyze the target proteins of DBR in bone marrow macrophages (BMMs). In vitro , BMMs were treated with RANKL and DBR, and TRAcP staining and actin belt staining were utilized to assess osteoclast activity. The inhibitory effects and underlying mechanisms of DBR on osteoclastogenesis and reactive oxygen species (ROS) generation were determined using real-time PCR, western blotting and immunofluorescence staining. An in vivo SIONFH rat model was set up to assess the curative impacts of DBR using micro-CT scanning and pathological staining.
Results
Bioinformatic tools revealed a pivotal role of osteoclast differentiation in SIONFH. Proteomic analysis identified 164 proteins binding in BMMs. In vitro assessments demonstrated that DBR hindered osteoclastogenesis by modulating the expression of specific genes and proteins, along with antioxidant proteins including TRX1 and Glutathione Reductase. Notably, the resin effectively inhibited the expression of crucial proteins, such as the phosphorylation of JNK and the nuclear localization of p65 within the TRAF6/JNK and NFκB signaling pathways. In vivo experiments further confirmed that DBR mitigated the onset of SIONFH in rats by curbing osteoclast and ROS activities.
Conclusion
These findings underscore the potential of Dragon’s Blood as an effective administration for early-stage SIONFH, shedding light on its therapeutic influence on ROS-mediated osteoclastic signaling pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China.
- School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
- Shenzhen institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Zitieren
APA
Liu, Y., Mo, L., Lu, H., Wei, Y., Zhang, J., Bennett, S., Xu, J., Zhou, C., Fang, B., & Chen, Z. (2023). Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1202888
Vancouver
Liu Y, Mo L, Lu H, Wei Y, Zhang J, Bennett S, et al. Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1202888
BibTeX
@article{Liu2023,
author = {Liu, Yuhao and Mo, Liang and Lu, Hongduo and Wei, Yangwenxiang and Zhang, Jiahao and Bennett, Samuel and Xu, Jiake and Zhou, Chi and Fang, Bin and Chen, Zhenqiu},
title = {Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1202888}
}
EUVIMED